@article{article, title = {{Effect of Empagliflozin on Kidney Biochemical and Imaging Outcomes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure with Reduced Ejection Fraction (SUGAR-DM-HF)}}, publisher = {{Ovid Technologies (Wolters Kluwer Health)}}, url = {{}}, year = {{2022}}, month = {{7}}, author = {{Lee MMY and Gillis KA and Brooksbank KJM and Allwood-Spiers S and Hall Barrientos P and Wetherall K and Roditi G and AlHummiany B and Berry C and Campbell RT and Chong V et al}}, doi = {{10.1161/circulationaha.122.059851}}, volume = {{146}}, journal = {{Circulation}}, issue = {{4}}, pages = {{364-367}}, note = {{Accessed on 2025/05/28}}}